Your RSA-2048 keys break in 2030. Find every one of them before attackers do.

CVE-2022-2068

CRITICAL

CVE-2022-2068 is a critical-severity (CVSS 9.8) OS Command Injection vulnerability. EPSS puts its 30-day exploitation probability at 95.8% (100th percentile). O3 Security confirms whether CVE-2022-2068 is actually reachable in your code before you act, and blocks exploitation at runtime until you patch.

The c_rehash script allows command injection

Published
Jun 21, 2022
Updated
Jul 22, 2026
Affected
0 pkgs
Patched
None yet
Exploits
None indexed

EPSS Exploitation Probability

via FIRST.org ↗
95.8%probability of exploitation in next 30 days
Very High Risk100th percentile0.00%
0.00%33.3%66.7%100.0%6.0%95.8%Jan 26May 26Jul 26

EPSS (Exploit Prediction Scoring System) is a daily probability model maintained by FIRST.org. It estimates the likelihood a CVE will be exploited in production environments within the next 30 days, derived from real-world threat intelligence signals.

Description

In addition to the c_rehash shell command injection identified in CVE-2022-1292, further circumstances where the c_rehash script does not properly sanitise shell metacharacters to prevent command injection were found by code review. When the CVE-2022-1292 was fixed it was not discovered that there are other places in the script where the file names of certificates being hashed were possibly passed to a command executed through the shell. This script is distributed by some operating systems in a manner where it is automatically executed. On such operating systems, an attacker could execute arbitrary commands with the privileges of the script. Use of the c_rehash script is considered obsolete and should be replaced by the OpenSSL rehash command line tool. Fixed in OpenSSL 3.0.4 (Affected 3.0.0,3.0.1,3.0.2,3.0.3). Fixed in OpenSSL 1.1.1p (Affected 1.1.1-1.1.1o). Fixed in OpenSSL 1.0.2zf (Affected 1.0.2-1.0.2ze).

Detection & mitigation playbook

Vulnerability
  1. Detect

    Scan your dependency tree (package-lock.json, pnpm-lock.yaml, requirements.txt, go.sum, etc.) for the affected component. O3's reachability analysis confirms whether the vulnerable code path is actually invoked in your application, so you act on real exposure instead of every transitive match.

  2. Remediation status

    No patched version of the affected component has shipped for CVE-2022-2068 yet. Where your build allows, override or pin the dependency away from the vulnerable range, and apply any maintainer-recommended mitigation.

  3. Mitigate without a patch

    If you can't upgrade right away: gate or disable the affected feature, validate untrusted input at the boundary, and avoid passing attacker-controlled data into the vulnerable path. O3's runtime protection blocks exploitation in production as an interim safeguard until the upgrade lands.

  4. How O3 protects you

    O3 pinpoints whether CVE-2022-2068 is reachable in your code and exactly where to fix it, then blocks exploitation in production at runtime until the patched version is deployed.

Tailored to CVE-2022-2068. Runtime protection reduces exposure until a permanent patch is applied and verified — it complements patching, it doesn't replace it.

Frequently Asked Questions

In addition to the c_rehash shell command injection identified in CVE-2022-1292, further circumstances where the c_rehash script does not properly sanitise shell metacharacters to prevent command injection were found by code review. When the CVE-2022-1292 was fixed it was not discovered that there are other places in the script where the file names of certificates being hashed were possibly passed to a command executed through the shell. This script is distributed by some operating systems in a manner where it is automatically executed. On such operating systems, an attacker could execute arbi
O3 Security · Impact-Aware SCA

Is CVE-2022-2068 in your dependencies?

O3 detects CVE-2022-2068 across dependencies and uses function-level reachability to confirm whether the vulnerable code path is actually reachable — not just present. No false positives.